Showing results (301-310 of 551) with videos related to

Sort By:
Pageof 56
Der Internist|October 21, 2003
[A 41 year-old male patient with fever of unknown origin and bacteremia with actinobacillus actinomycetemcomitans]S Rosenkranz, K Töpelt, H Seifert, et al.
Biochemical Pharmacology|December 1, 1982
Effect of vanadium in the +5, +4 and +3 oxidation states on cardiac force of contraction, adenylate cyclase and (Na+ + K+)-ATPase activityW Schmitz, H Scholz, E Erdmann, et al.
Hypertension (Dallas, Tex. : 1979)|May 1, 1995
Treatment in hypertensive cardiac hypertrophy, II. Postreceptor eventsM Böhm, C Gräbel, M Flesch, et al.
The Clinical Investigator|July 1, 1993
Percutaneous transluminal coronary angioplasty of focal coronary lesions after cardiac transplantationW von Scheidt, B M Kemkes, B Reichart, et al.
Journal of the American College of Cardiology|January 1, 1995
Evidence for reduction of norepinephrine uptake sites in the failing human heartM Böhm, K La Rosée, R H Schwinger, et al.
Deutsche Medizinische Wochenschrift (1946)|December 14, 2011
[70-year-old woman with cardiac hypertrophy and severe pulmonary hypertension: pre- or postcapillary?]D Dumitrescu, F Gerhardt, T Viethen, et al.
British Journal of Pharmacology|September 1, 1989
Inotropic response to DPI 201-106 in the failing human heartM Böhm, F Diet, B Kemkes, et al.
Journal of Cardiovascular Electrophysiology|June 4, 1999
Atrial sensing and AV synchrony in single lead VDD pacemakers: a prospective comparison to DDD devices with bipolar atrial leadsU K Wiegand, F Bode, R Schneider, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 9, 2013
Inhibition of cardiac Kv1.5 and Kv4.3 potassium channels by the class Ia anti-arrhythmic ajmaline: mode of actionF Fischer, N Vonderlin, E Zitron, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 31, 2006
Cyclosporine withdrawal improves renal function in heart transplant patients on reduced-dose cyclosporine therapyC A Gleissner, A Doesch, P Ehlermann, et al.
Pageof 56